Protection of Unborn Babies Strengthening

By Jackson Kincaid

In Brief:

A judge in Texas may have opened the door for overturning the legality of the FDA abortion pill, mifepristone. Not only did the FDA approve this medication under false pretenses, it wrongfully used a loophole designed for emergencies to gain faster approval. 

The Background: 

Trump-appointed U.S. District Judge Matthew Kacsmaryk (R-TX), has stepped up the fight for the right to life for all Americans, no matter their age.

The lawsuit was filed by The Alliance for Defending Freedom (ADF), a Christian legal advocacy group, on November 18 in an Amarillo, Texas, federal court on behalf of the Alliance for Hippocratic Medicine, a coalition of physicians who oppose abortion, against the FDA.

In a statement given to Newsweek, the ADF stated:

"The FDA has failed its responsibility to protect women and girls from chemical abortion drugs—it never had the authority or the studies to approve chemical abortion drugs in the first place.” 

The ADF further stated that the FDA failed to abide by its legal obligations" by not studying "the safety of the drugs under the labeled conditions of use, ignoring the potential impacts of the hormone-blocking regimen on the developing bodies of adolescent girls, disregarding the substantial evidence that chemical abortion drugs cause more complications than surgical abortions and eliminating necessary safeguards for pregnant girls and women who undergo this dangerous drug regimen."

The lawsuit is expected to head to the Supreme Court as the Biden Administration is already fighting this judge. 

Notable Quotes: 

"The Court does not second-guess FDA's decision-making lightly. But here, FDA acquiesced on its legitimate safety concerns — in violation of its statutory duty — based on plainly unsound reasoning and studies that did not support its conclusions. There is also evidence indicating FDA faced significant political pressure to forego its proposed safety precautions to better advance the political objective of increased 'access; to chemical abortion — which was the 'whole idea of mifepristone.'" – Judge Matthew Kacsmaryk